News

Deal Announcements

Avaxia Adds New Venture Capital Financing

Tuesday, January 10, 2012 5:30:00 AM PDT | VentureDeal Staff
   Lexington, Massachusetts  --  Biotechnology company Avaxia Biologics has secured approximately $1.2 million in additional venture capital investment, according to an SEC regulatory filing.

Avaxia says that is developing "oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract."

Investors in the financing were not disclosed.

The company is still seeking approximately $1 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1